ORBIMED ADVISORS LLC 13D/13G Filings for Sierra Oncology, Inc. (SRRA)

ORBIMED ADVISORS LLC 13D and 13G filings for Sierra Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-03-15
4:30 pm
Unchanged		2022-03-1013DSierra Oncology, Inc.
SRRA		ORBIMED ADVISORS LLC3,044,753
12.200%		0
(Unchanged)		Filing
2022-02-02
4:33 pm
Unchanged		2022-01-3113DSierra Oncology, Inc.
SRRA		ORBIMED ADVISORS LLC3,044,753
15.300%		0
(Unchanged)		Filing
2021-11-05
4:26 pm
Purchase		2021-11-0513DSierra Oncology, Inc.
SRRA		ORBIMED ADVISORS LLC3,044,753
18.100%		3,033,090increase
(+26006.64%)		Filing